XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenue:        
Total revenue $ 9,480 $ 0 $ 105,322 $ 0
Operating expenses:        
Research and development 34,897 31,200 102,375 105,334
General and administrative 8,502 9,290 26,738 29,398
Total operating expenses 43,399 40,490 129,113 134,732
Loss from operations (33,919) (40,490) (23,791) (134,732)
Other income (expense)        
Interest income 430 405 2,523 1,687
Interest expense (2,734) (3,343) (8,779) (10,272)
Other income, net 4,288 3,420 9,851 11,648
Total other income, net 1,984 482 3,595 3,063
Loss before provision (benefit) for income taxes (31,935) (40,008) (20,196) (131,669)
Provision (benefit) for income taxes (1,132) 0 3,303 0
Net loss (30,803) (40,008) (23,499) (131,669)
Other comprehensive income (loss):        
Foreign currency translation (2,260) (170) (2,244) (146)
Unrealized gain on marketable securities 547 33 363 102
Other comprehensive loss (1,713) (137) (1,881) (44)
Comprehensive loss $ (32,516) $ (40,145) $ (25,380) $ (131,713)
Net loss per share, basic (in dollars per share) $ (0.14) $ (0.21) $ (0.10) $ (1.03)
Net loss per share, diluted (in dollars per share) $ (0.14) $ (0.21) $ (0.10) $ (1.03)
Weighted average common shares outstanding, basic (in shares) 226,346,058 192,883,209 226,101,727 128,092,499
Weighted average common shares outstanding, diluted (in shares) 226,346,058 192,883,209 226,101,727 128,092,499
Revenue from sale of licenses        
Revenue:        
Total revenue $ 0 $ 0 $ 88,751 $ 0
Revenue from contracts with collaborators        
Revenue:        
Total revenue $ 9,480 $ 0 $ 16,571 $ 0